[1]
“Formulation Development of Rotigotine Transdermal System Using Dot-Matrix Technology”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 4, pp. 404–414, Jul. 2020, doi: 10.25004/IJPSDR.2020.120414.